Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 9/2019

Ausgabe 9/2019

Inhaltsverzeichnis ( 13 Artikel )

14.08.2019 | Original Article | Ausgabe 9/2019 Open Access

Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cells

Stefanie Koristka, Pauline Ziller-Walter, Ralf Bergmann, Claudia Arndt, Anja Feldmann, Alexandra Kegler, Marc Cartellieri, Armin Ehninger, Gerhard Ehninger, Martin Bornhäuser, Michael P. Bachmann

17.08.2019 | Original Article | Ausgabe 9/2019

Successful combination therapy of systemic checkpoint inhibitors and intralesional interleukin-2 in patients with metastatic melanoma with primary therapeutic resistance to checkpoint inhibitors alone

David Rafei-Shamsabadi, Saskia Lehr, Dagmar von Bubnoff, Frank Meiss

19.08.2019 | Original Article | Ausgabe 9/2019

A VEGFR2–MICA bispecific antibody activates tumor-infiltrating lymphocytes and exhibits potent anti-tumor efficacy in mice

Yao Xu, Xinrong Zhang, Yong Wang, Mingzhu Pan, Min Wang, Juan Zhang

23.08.2019 | Original Article | Ausgabe 9/2019

Morphomolecular analysis of the immune tumor microenvironment in human head and neck cancer

Mohamed Badr, Korinna Jöhrens, Michael Allgäuer, Melanie Boxberg, Wilko Weichert, Ingeborg Tinhofer, Carsten Denkert, Peter Schirmacher, Albrecht Stenzinger, Jan Budczies

23.08.2019 | Original Article | Ausgabe 9/2019

Melanoma-conditioned medium promotes cytotoxic immune responses by murine bone marrow-derived monocytes despite their expression of ‘M2’ markers

Liam Friel Tremble, Anne C. Moore, Patrick F. Forde

27.08.2019 | Original Article | Ausgabe 9/2019

Safety and efficacy of PD-1 blockade-activated multiple antigen-specific cellular therapy alone or in combination with apatinib in patients with advanced solid tumors: a pooled analysis of two prospective trials

Lijun Liang, Yixuan Wen, Rong Hu, Lei Wang, Youyou Xia, Chenxi Hu, Yun Qiao, Xiaowei Geng, Ting Chen, Jiayan Fei, Kaiyuan Hui, Xiaodong Jiang

28.08.2019 | Original Article | Ausgabe 9/2019

An optimized retinoic acid-inducible gene I agonist M8 induces immunogenic cell death markers in human cancer cells and dendritic cell activation

Luciano Castiello, Alessandra Zevini, Elisabetta Vulpis, Michela Muscolini, Matteo Ferrari, Enrico Palermo, Giovanna Peruzzi, Christian Krapp, Martin Jakobsen, David Olagnier, Alessandra Zingoni, Angela Santoni, John Hiscott

09.09.2019 | Original Article | Ausgabe 9/2019

TNFSF4 (OX40L) expression and survival in locally advanced and metastatic melanoma

Jason Roszik, Ettai Markovits, Paula Dobosz, Adi Layani, Keren Slabodnik-Kaner, Erez N. Baruch, Guy Ben-Betzalel, Elizabeth Grimm, Raanan Berger, Yehezkel Sidi, Jacob Schachter, Ronnie Shapira-Frommer, Dror Avni, Gal Markel, Raya Leibowitz-Amit

05.09.2019 | Original Article | Ausgabe 9/2019

Tumor-induced peripheral immunosuppression promotes brain metastasis in patients with non-small cell lung cancer

Yuping D. Li, Jonathan B. Lamano, Jason B. Lamano, Jessica Quaggin-Smith, Dorina Veliceasa, Gurvinder Kaur, Dauren Biyashev, Dusten Unruh, Orin Bloch

12.09.2019 | Original Article | Ausgabe 9/2019

Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature

Emily Hinchcliff, Cherie Paquette, Jason Roszik, Sarah Kelting, Mark H. Stoler, Samuel C. Mok, Tsz-Lun Yeung, Qian Zhang, Melinda Yates, Weiyi Peng, Patrick Hwu, Amir Jazaeri

18.09.2019 | Original Article | Ausgabe 9/2019 Open Access

Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer

Danyang Sun, Junxun Ma, Jinliang Wang, Chun Han, Yuanyu Qian, Guangying Chen, Xiaoyan Li, Juan Zhang, Pengfei Cui, Wushuang Du, Zhaozhen Wu, Shixue Chen, Xuan Zheng, Zhichao Yue, Jia Song, Chan Gao, Xiaochen Zhao, Shangli Cai, Yi Hu

03.09.2019 | Original Article | Ausgabe 9/2019

Independent expression of circulating and tissue levels of PD-L1: correlation of clusters with tumor metabolism and outcome in patients with non-small cell lung cancer

Fabio Grizzi, Angelo Castello, Dorina Qehajaj, Luca Toschi, Sabrina Rossi, Daniela Pistillo, Valentina Paleari, Giulia Veronesi, Pierluigi Novellis, Simona Monterisi, Rossana Mineri, Daoud Rahal, Egesta Lopci

03.09.2019 | Clinical Trial Report | Ausgabe 9/2019

A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients

Benjamin Weide, Thomas Eigentler, Chiara Catania, Paolo Antonio Ascierto, Stefano Cascinu, Jürgen C. Becker, Axel Hauschild, Antonella Romanini, Riccardo Danielli, Reinhard Dummer, Uwe Trefzer, Giuliano Elia, Dario Neri, Claus Garbe

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise